CLNO hit a high of .193 yesterday morning, before we observed a lunchtime pullback to .10. On the intraday chart (below), the RSI started to look oversold, and the PPO crossed over, giving us an indication that it was a good time to consider re-entry. In a dip-and-rip scenario, we had a chance at up to 70% in intraday gains as the stock traveled back to the .17-range.
From our original alert at .0055, CLNO has risen as much as 3409%
Las Vegas, NV, Jun 21, 2013 (WORLD STOCK WIRE via COMTEX) — CleanTech Transit, Inc. (OTCQB: CLNO) announced today that it has acquired 81% of the issued and outstanding shares of Discovery Carbon Environmental Securities Corporation (“Discovery”), a Nevada corporation. The acquisition advances the strategy of developing significant market share in the alternative clean energy sector. Discovery’s proprietary GreenTrees(TM) for renewable energy, and EvoCert(TM) environmental credits for offsetting business and individual carbon foot prints are some of the exciting products Discovery provides to clients throughout the world.
For More Info on CLNO Visit:
Our interest in SPY Calls yesterday morning paid instant dividends regardless of which levels we chose. Take a look at the daily ranges on the following contracts:
$156 Calls – Low: 2.29 – High: 3.43 (Close: 3.00)
$156.50 Calls – Low: 2.00 – High: 3.03 (Close: 2.60)
$157 Calls – Low: 1.60 – High: 2.59 (Close: 2.13)
$157.50 Calls – Low: 1.35 – High: 2.20 (Close: 1.83)
$158 Calls: Low: 1.05 – High: 1.80 (Close: 1.48)
CombiMatrix Corp. CBMX
CBMX appeared on our extended watchlist for the second time yesterday since April 4th.
Back in April, we saw a move from 3.46-4.62 following our alert on the stock.
Yesterday, a similarly-sized spike took CBMX on a ride from 3.35 to 4.60 on the heels of an important announcement from the company regarding its approval by the New York State Board of Health to market its prenatal miscarriage analysis tests throughout the state. We refer you to the following:
IRVINE, Calif., June 25, 2013 (GLOBE NEWSWIRE) — CombiMatrix Corporation (CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that its chromosomal microarray analysis (CMA) test for miscarriage analysis has received conditional approval from the New York State‘s Department of Health for testing on patient samples from the state. >>>WHOLE RELEASE
Other Extended Watchlist Winners:
While we’re on the subject of good performers to come off of our extended watchlist, we must turn our attention to a couple of our favorite cannabis stocks, MJNA, and HEMP. Our coverage of hemp-related plays has tapered recently, as we’ve had many other pressing issues to discuss. But it seems that we re-introduced them at a good time yesterday.
HEMP was as low as .021 before hitting a high of .028, a move of 33%
MJNA traded from .131 on up to .1453. That was good for an intraday gain of 11%
EWRL, PGRX(Coming off of recent lows), RSOL, LIVE,